Abstract:Cuproptosis is a recently identified copper-dependent form of nonapoptotic cell death and holds great prospect in cancer treatment. One of the most intriguing aspects of cuproptosis is its ability to synergize with apoptosis-based cancer treatments. Herein, we presented a novel approach using copper-coordinated nanoassemblies (CCNAs) that were constructed by incorporating a photosensitizer Zinc Phthalocyanine (ZnPc)-chemotherapeutic (DOX) prodrug with a thioketal (TK) spacer and an IDO inhibitor (1-methyl tryptophan, 1-MT) as building blocks for Cu 2+ -coordination self-assembly to achieve combinational apoptosis-cuproptosis and immunotherapy. Upon NIR laser irradiation, the ZnPc component of CCNAs exhibited a photodynamic effect that generated reactive oxygen species (ROS). This triggered the release of DOX, leading to enhanced tumor cell apoptosis. Additionally, the presence of Cu 2+ in the CCNAs not only enhanced the photodynamic process by catalyzing oxygen generation but also promoted the aggregation of toxic mitochondrial proteins, leading to cell cuproptosis. Importantly, the intensified cuproptosis-apoptosis effect triggered an immunogenic cell death (ICD) response. The released 1-MT complemented this response by reversing the immunosuppressive tumor microenvironment (ITM), synergistically amplifying anti-tumor immunity and suppressing the growth of primary and distant tumors. The findings of this study provide a new perspective on potential cancer treatments based on cuproptosis-apoptosis synergistic immunotherapy and stimulate further research in the design of advanced metal-coordinated nanomedicines. Statement of Significance : The combination of cuproptosis and apoptosis that act with different mechanisms holds enormous potential in cancer treatment. Here, copper-coordinated nanoassemblies (CCNAs) based on photosensitizer-chemo prodrugs and checkpoint inhibitors were constructed for mediating cuproptosis-apoptosis and subsequently promoting cancer immunotherapy. CCNAs not only promoted the photodynamic effect and activation of chemotherapy through catalyzing the generation of oxygen but also induced toxic mitochondrial protein aggregation, leading to cell cuproptosis. These synergistic antitumor effects triggered robust immune responses with the aid of immune checkpoint blockade, almost eradicating primary tumors and inhibiting distant tumors by around 83 % without systemic toxicity.

Tumor Metabolism Aiming Cu2- xS Nanoagents Mediate Photothermal-Derived Cuproptosis and Immune Activation

Copper-Coordinated Nanoassemblies based on Photosensitizer-Chemo Prodrugs and Checkpoint Inhibitors for Enhanced Apoptosis-Cuproptosis and Immunotherapy

Responsive Plasmonic Hybrid Nanorods Enables Metabolism Reprogramming Via Cuproptosis-Photothermal Combined Cancer Therapy

In Situ Sacrificial Growth of Metastable Copper-Enriched Nanomedicine for Cuproptosis-Based Synergistic Cancer Therapy

Tumor Microenvironment Activated MXene-protected Cu2O Heterojunctions Induce Tumor-Specific Cuproptosis for Enhanced Sono-Immunotherapy

Regulating Copper Homeostasis of Tumor Cells to Promote Cuproptosis for Enhancing Breast Cancer Immunotherapy

Photoinduced Cuproptosis with Tumor‐Specific for Metastasis‐Inhibited Cancer Therapy

Cuproptosis and Serine Metabolism Blockade Triggered by Copper‐Based Prussian Blue Nanomedicine for Enhanced Tumor Therapy

Photothermally Triggered Copper Payload Release for Cuproptosis-Promoted Cancer Synergistic Therapy

A copper missile-triggered power coalescence and death vortex within tumor cell mitochondria for synergistic cuproptosis/phototherapy/chemotherapy

A Metabolic Intervention Strategy for Enhanced Ferroptosis/cuproptosis Activation and Boosted Anti-Tumor Immunity

An Intelligent Cupreous Nanoplatform with Self-Supplied H 2 O 2 and Cu 2+ /Cu + Conversion to Boost Cuproptosis and Chemodynamic Combined Therapy

An Intelligent Cupreous Nanoplatform with Self-Supplied H2O2 and Cu2+/Cu+ Conversion to Boost Cuproptosis and Chemodynamic Combined Therapy

An Enzyme-Engineered Nonporous Copper(I) Coordination Polymer Nanoplatform for Cuproptosis-Based Synergistic Cancer Therapy

Tumor microenvironment activation amplify oxidative stress promoting tumor energy remodeling for mild photothermal therapy and cuproptosis

Near‐infrared Activatable Copper Nanoplatforms Synergize with the 5‐Azacytidine Prodrug to Potentiate Cuproptosis

Cuprous Oxide Nanocomposites with Photothermal (PTT) and Chemical Dynamics (CDT) Effects Induce Cuproptosis in Breast Cancer Using the Strategy of Increasing Inflow and Reducing Outflow

Cuproptosis Nanomedicine: Clinical Challenges and Opportunities for Anti-Tumor Therapy

Thermal-triggered Mitochondrial Oxidative Phosphorylation-Enhanced Nanodrug Sensitizes Cuproptosis with Amplified Anti-Tumor Immunity

Copper(II)-Based Nano-Regulator Correlates Cuproptosis Burst and Sequential Immunogenic Cell Death for Synergistic Cancer Immunotherapy

Cuproptosis-immunotherapy Using PD-1 Overexpressing T Cell Membrane-Coated Nanosheets Efficiently Treats Tumor.